1. Home
  2. PCSA vs DTCK Comparison

PCSA vs DTCK Comparison

Compare PCSA & DTCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

HOLD

Current Price

$0.27

Market Cap

14.7M

Sector

Health Care

ML Signal

HOLD

Logo Davis Commodities Limited

DTCK

Davis Commodities Limited

HOLD

Current Price

$0.36

Market Cap

12.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCSA
DTCK
Founded
2011
1999
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
12.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
PCSA
DTCK
Price
$0.27
$0.36
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
1.1M
1.0M
Earning Date
11-06-2025
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$132,369,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.29
52 Week High
$1.50
$6.89

Technical Indicators

Market Signals
Indicator
PCSA
DTCK
Relative Strength Index (RSI) 48.05 39.99
Support Level $0.27 $0.33
Resistance Level $0.30 $0.41
Average True Range (ATR) 0.02 0.08
MACD 0.00 -0.00
Stochastic Oscillator 62.34 19.97

Price Performance

Historical Comparison
PCSA
DTCK

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

About DTCK Davis Commodities Limited

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore, which specializes in the trading of three main categories of agricultural commodities, namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa, and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage, and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil, and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

Share on Social Networks: